At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
olanzapinedrug
Likely dose
olanzapine 2.5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Brain Correlates of Olanzapine Treatment Response in BPD
In Brief
A clinical study evaluating olanzapine for Borderline Personality Disorder. Completed, enrolled 19 participants across 1 site.
Detailed Summary
The overall design of the study is to perform both a PET and MRI scan on objectively identified borderline personality disorder patients, to treat them with olanzapine for 8 weeks, and to then re-scan the patients with PET.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBorderline Personality Disorder
CountriesUnited States
CollaboratorsEli Lilly and Company
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2005
First PostedJan 2006
Primary CompletionApr 2008
Study CompletionDec 2008
TodayJul 2026
First PostedJan 11, 2006
Enrollment StartDec 1, 2005
Primary CompletionApr 1, 2008
Study CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 20.5 years ago
Interventions
olanzapinedrug
Olanzapine 2.5mg by mouth at bedtime x2 weeks, then Olanzapine 5mg by mouth at bedtime x2 weeks, then Olanzapine 7.5mg by mouth at bedtime x4 weeks.